Abryl Laboratories Private Limited

Pharmaceutical company manufacturing sterile liquids, lyophilized and ophthalmic products under various brands.

2016 | Chandigarh, Chandigarh (India) | Active
Last Updated: July 17, 2024

Abryl Laboratories Profile

Key Indicators

  • Authorised Capital ₹ 40.00 Cr
  • Paid Up Capital ₹ 36.31 Cr
  • Company Age 9 Year, 30 Days
  • Last Filing with ROC 31 Mar 2023
  • Satisfied Charges ₹ 3.33 M
  • Revenue Growth -74.80%
  • Profit Growth 83.60%
  • Ebitda 12.86%
  • Net Worth -0.59%
  • Total Assets 13.77%

About Abryl Laboratories

Abryl Laboratories Private Limited (ALPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 January 2016 (Nine years 30 days old ). Its registered office is in Chandigarh, Chandigarh, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 40.00 Cr and a paid-up capital of Rs 36.31 Cr.

The company has closed loans amounting to ₹3.33 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.

The Key Managerial Personnel (KMP) at Abryl Laboratories Private Limited India is Arshpreet Guliani as COMPANY SECRETARY. Vijay Kumar and Jayant Singla serve as directors at the Company.

Company Details

  • Location

    Chandigarh, Chandigarh, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    abryl.in

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U24232CH2016PTC035904

  • Company No.

    035904

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    20 Jan 2016

  • Date of AGM

    30 Sep 2023

  • Date of Balance Sheet

    31 Mar 2023

  • Listing Status

    Unlisted

  • ROC Code

    Roc Chandigarh

Industry

Pharma

Who are the key members and board of directors at Abryl Laboratories?

Executive Team (1)

NameDesignationAppointment DateStatus
Arshpreet Guliani Company Secretary15-Apr-2024Current

Board Members (2)

NameDesignationAppointment DateStatus
Vijay Kumar Country flag representing In Director 20-Jan-2016Current
Jayant Singla Country flag representing In Director 20-Jan-2016Current

Financial Performance of Abryl Laboratories.

Abryl Laboratories Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 74.8% decrease. The company also saw a substantial improvement in profitability, with a 83.6% increase in profit. The company's net worth dipped by a decrease of 0.59%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-74.80%
Revenue from Operations
-75.10%
Total Assets
13.77%
Profit or Loss
83.60%
Net Worth
-0.59%
EBITDA
12.86%

What is the Ownership and Shareholding Structure of Abryl Laboratories?

In 2023, Abryl Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹0

Satisfied Charges

₹0.33 Cr

Charges Breakdown by Lending Institutions

  • Hdfc Bank Limited : 0.33 Cr

Latest Charge Details

DateLenderAmountStatus
19 Aug 2019Hdfc Bank Limited₹1.66 MSatisfied
19 Aug 2019Hdfc Bank Limited₹1.66 MSatisfied

How Many Employees Work at Abryl Laboratories?

Abryl Laboratories has a workforce of 449 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Abryl Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Abryl Laboratories's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Abryl Laboratories

Recent activity within the organization

  • Director Appointment

    Arshpreet Kaur Guliani was appointed as a Company Secretary was appointed as a Company Secretary on 15 Apr 2024 & has been associated with this company since 10 months 5 days .

    15 Apr 2024

  • Annual General Meeting

    Abryl Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.

    30 Sep 2023

  • Balance Sheet

    Abryl Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Chandigarh.

    31 Mar 2023

  • Charges

    A charge registered on 19 Aug 2019 via Charge ID 100287353 with Hdfc Bank Limited was fully satisfied on 16 Jun 2021.

    16 Jun 2021

  • Charges

    A charge registered on 19 Aug 2019 via Charge ID 100287356 with Hdfc Bank Limited was fully satisfied on 16 Jun 2021.

    16 Jun 2021

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 0.17 Cr with Charge ID 100287353 was registered on 19 Aug 2019.

    19 Aug 2019

Frequently asked questions

  • Abryl Laboratories Private Limited was incorporated on 20 Jan 2016.

  • The authorized share capital of Abryl Laboratories Private Limited is ₹ 40.00 Cr and paid-up capital is ₹ 36.31 Cr.

  • Currently 3 directors are associated with Abryl Laboratories Private Limited.

    • Vijay Kumar
    • Jayant Singla
    • Arshpreet Kaur Guliani
  • As per Ministry of Corporate Affairs (Mca), the registered address of Abryl Laboratories Private Limited is Sector-11 House No. 63, Chandigarh, India, 160011.

  • The corporate identification number (CIN) of Abryl Laboratories Private Limited is U24232CH2016PTC035904 and the company number is 035904 as per Ministry of Corporate Affairs (MCA).

  • The Official website of Abryl Laboratories Private Limited is https://www.abryl.in

  • According to the financial reports for the fiscal year 2023, the revenue trend for Abryl Laboratories Private Limited has fallen by -74.80%.

  • As Per 2023 financial reports, 449 employees are currently employed by Abryl Laboratories Private Limited.

  • The financial reports for the fiscal year 2023 indicates that The net worth of Abryl Laboratories Private Limited has experienced an downturn of -0.59%.

  • The most recent Balance Sheet for Abryl Laboratories Private Limited was filed with the ROC on 31 Mar 2023.

People also Viewed

Similar Companies Based on Drug Formulation & Development